Axena Health, Inc. (Axena Health), a medical device company relentlessly dedicated to women’s health, today announced that Cigna Healthcare (Cigna), one of the largest healthcare insurance providers in the United States with approximately 15 million members, has added the Leva Pelvic Health System as a covered treatment for stress, urgency and mixed urinary incontinence (UI) in women.

Interview with Milena M. Weinstein, MD, associate professor of obstetrics, gynecology, and reproductive biology at Harvard Medical School. Dr. Weinstein was the lead study author for the Digital Therapeutic Device for Urinary Incontinence 8-week RCT as well as the 6- & 12-month follow-up study. This interview highlights the positive results of both studies including the long-term durable efficacy of Leva for at least a year.

Read the article in Contemporary OB/GYN

Axena Health, Inc. (Axena Health), a newly-formed commercial-stage medical device company focused on women’s pelvic health, today announced a $25 million Series A investment from AXA IM Alts through its Global Healthcare Private Equity Strategy.